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Members of the immunity-related GTPase (IRG) family
are interferon-inducible resistance factors against a broad
spectrum of intracellular pathogens including Toxoplasma
gondii. The molecular mechanisms governing the function
and regulation of the IRG resistance system are largely
unknown. We ﬁnd that IRG proteins function in a system
of direct, nucleotide-dependent regulatory interactions be-
tween family members. After interferon induction but before
infection, the three members of the GMS subfamily of IRG
proteins, Irgm1, Irgm2 and Irgm3, which possess an atypical
nucleotide-binding site, regulate the intracellular positioning
of the conventional GKS subfamily members, Irga6 and
Irgb6. Following infection, the normal accumulation of
Irga6 protein at the parasitophorous vacuole membrane
(PVM) is nucleotide dependent and also depends on the
presence of all three GMS proteins. We present evidence
that an essential role of the GMS proteins in this response
is control of the nucleotide-bound state of the GKS proteins,
preventing their GTP-dependent activation before infection.
Accumulation of IRG proteins at the PVM has previously
b e e ns h o w nt ob ea s s o c i a t e dw i t hab l o c ki np a t h o g e n
replication: our results relate for the ﬁrst time the enzymatic
properties of IRG proteins to their role in pathogen resistance.
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Introduction
Several families of interferon-inducible large GTPases (in-
cluding Mx proteins, guanylate-binding proteins (GBP) and
immunity-related GTPases (IRG)) are involved in cell-auton-
omous resistance mechanisms functional against intracellu-
lar pathogens. The powerful biological activity of the IRG
proteins (immunity-related or p47 GTPases) against a range
of pathogens has been extensively reviewed (e.g. Martens
and Howard, 2006). There have, however, been no reports
relating the GTP binding and hydrolysis cycles of the IRG
proteins to their activity in pathogen defence. We address this
issue in the context of the well-documented ability of IRG
proteins to assemble rapidly on the parasitophorous vacuole
membrane (PVM) of the intracellular protozoal parasite,
Toxoplasma gondii, and to participate in its destruction
(Martens et al, 2005; Ling et al, 2006).
The IRG family is represented by 25 IRG coding units of
about 1.2kb in the C57BL/6 mouse genome representing 21
genes, as 4 of these are transcribed as pairs to generate
tandem B2.4kb products (Bekpen et al, 2005 and unpub-
lished data). Three IRG genes (Irgm1–3) encode proteins with
the non-canonical sequence GX4GMS in place of the other-
wise universally conserved GX4GKS in the ﬁrst nucleotide-
binding motif (G1), giving rise to the subfamily name IRGM
(Bekpen et al, 2005). As a convenient shorthand, we desig-
nate the IRGM subfamily members and the IRG proteins with
the conventional G1 motif as GMS and GKS, respectively. Of
the IRG genes studied so far by genomic knockout, Irgm1
(LRG-47), Irgm3 (IGTP) and Irgd (IRG-47) have all been
shown to be non-redundantly required for resistance to
T. gondii (Taylor et al, 2000; Collazo et al, 2001). Irga6 (IIGP)
and Irgb6 (TGTP) also participate in the mechanism of
cellular resistance to this parasite as its replication is unrest-
ricted following expression of functionally dominant-negative
mutants (Irga6-K82A, Irgb6-K69A) of these two IRG proteins
in IFN-induced primary mouse astrocytes (Martens et al,
2005 and unpublished data). Irga6, Irgb6, Irgd, Irgm2
(GTPI) and Irgm3 have been shown to accumulate at
T. gondii parasitophorous vacuoles (PVs) (Martens et al,2 0 0 5 ;
Ling et al, 2006). Accumulation of IRG proteins at the PVM is
followed by vesiculation and disruption of the PVM and
death of the parasite. The modes of action of individual IRG
proteins in resistance to T. gondii may, however, not all be the
same. The accumulation of several family members at the
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2495PVM and the morphological disruption of the vacuole suggest
an effector action at this site. However, Irgm1 does not
localise to the PVM (Butcher et al, 2005; Martens et al,
2005 and unpublished data) and must therefore contribute
to resistance in another way. In the present paper, we show
that an essential function of Irgm1 as well as of Irgm2 and
Irgm3 is to regulate other IRG proteins through control of
their GTPase cycle.
There is an early report that partially puriﬁed Irgm3, a
GMS protein, can bind GTP despite its anomalous P-loop
sequence (Taylor et al, 1996). However, the GKS protein Irga6
is the only IRG family member for which the biochemical
properties have been examined in detail and the crystal
structure has been solved (Uthaiah et al, 2003; Ghosh et al,
2004). Puriﬁed, bacterially expressed Irga6 protein forms
oligomeric structures in a GTP-dependent manner in vitro
and hydrolyses GTP to GDP cooperatively. Nothing is known
about the function, timing or regulation of the Irga6 GTPase
cycle in vivo by heterologous regulators, such as GTPase-
activating proteins (GAPs), guanine nucleotide exchange
factors or guanine nucleotide dissociation inhibitors (GDIs).
Thus, there is so far no direct link between the biochemical
properties of the IRG proteins and their biological activity in
cell-autonomous resistance. The fact that all three reported
genomic knockouts of IRG genes display a non-redundant
loss of T. gondii resistance suggested that different IRG
proteins might interact with each other to exercise their
function. Furthermore, the strikingly suppressive effects of
Irga6-K82A and Irgb6-K69A on T. gondii resistance and PVM
localisation in IFN-induced cells, noted above, was also
compatible with an interactive model of non-redundancy.
Furthermore, these mutants were designed to interfere with
the nucleotide-binding site, implicating the control of the
GTPase cycle in Irga6 and Irgb6 function in vivo. Both
Irga6-K82A and Irgb6-K69A contain mutations of the lysine
in the universally conserved P-loop GKS motif homologous to
p21 Ras K16. Here, we show that the biochemical character-
istic of Irga6-K82A is not the expected failure to bind GTP but
rather a failure to hydrolyse it once bound. Irga6-K82A is thus
a constitutively active form of the protein. WT Irga6 behaves
as if it too is constitutively active in vivo in the absence of the
three GMS proteins Irgm1, Irgm2 and Irgm3, suggesting that
these latter proteins normally suppress or attenuate the
spontaneous conversion of Irga6 into the active GTP-bound
state. In the absence of this regulatory control, Irga6, such as
Irga6-K82A, accumulates in cytoplasmic aggregates and fails
to reach the PVM of infecting T. gondii. Irgb6 shows proper-
ties largely similar but not identical to those of Irga6, and we
ﬁnd that the regulatory interactions of the GMS proteins with
these two GKS proteins are associated with direct nucleotide-
dependent contact between the GTPases. We conclude that
assembly of IRG proteins at the T. gondii PVM depends on the
timing and subcellular location of nucleotide exchange,
which is in turn governed by speciﬁc, nucleotide-dependent
regulatory interactions between the three GMS proteins and
members of the GKS group.
Results
Irga6-K82A is constitutively active and Irga6-S83N
is inert
K82 of Irga6 is homologous to K16 of Ras; mutations at this
P-loop residue have been shown to render several GTPases
deﬁcient in GTP binding (Sigal et al, 1986; Pitossi et al, 1993;
Praefcke et al, 2004). Irga6-K82A has wild-type (WT) afﬁnity
for GDP (Uthaiah, 2002; Figure 1A and C) and also signiﬁcant
binding activity for methylanthraniloyl-(mant)-GTPgS( m G T P gS)
(Figure 1B and C), with a calculated equilibrium afﬁnity
constant similar to WT Irga6. The absolute increase in ﬂuor-
escence signal on mGTPgS binding was, however, unusually
small (see Materials and methods), so this afﬁnity estimate
should be considered preliminary. Consistent with its afﬁnity
for GTP, Irga6-K82A, similar to WT Irga6 (Uthaiah et al, 2003),
formed oligomers in vitro on addition of GTP (Figure 1D and
E). In case of WT Irga6, the oligomers resolved as GTP was
hydrolysed (Uthaiah et al, 2003), whereas Irga6-K82A oligo-
mers formed slowly and continuously and did not resolve
over the time course of the experiment. We further showed
that Irga6-K82A shows no net GTP turnover activity over a
wide protein concentration range (Figure 1F and G). Thus,
Irga6-K82A, despite its dominant inhibitory effect on resis-
tance to T. gondii (Martens et al, 2005), may become consti-
tutively active in vivo, locked in the GTP-bound state.
The S17N mutation of Ras retains WTafﬁnity for GDP but
is unable to bind GTP, and is therefore dominant negative,
locked in the inactive state (Feig and Cooper, 1988). The
homologous mutation of Irga6, S83N, however, had greatly
reduced binding afﬁnity for both nucleotides (Figure 1A–C),
did not hydrolyse GTP (Figure 1F) and did not form GTP-
dependent oligomers (Figure 1D–E). Irga6-S83N, therefore,
provided a negative control protein for the documentation of
nucleotide-dependent processes mediated by Irga6.
Irga6 localisation to the T. gondii PVM is regulated
by IFN
Irga6 transfected into unstimulated mouse L929 ﬁbroblasts
accumulated in cytoplasmic aggregates (Martens et al, 2004),
instead of the smooth ER localisation characteristic of
the endogenous, IFN-induced Irga6 protein (Figure 2A).
Cells expressing such aggregates proliferated normally
(Supplementary Figure S1) but showed striking distension
of the ER lumen (Supplementary Figure S2). These results
suggest that the correct cellular localisation of Irga6 requires
the concomitant expression of additional IFNg-inducible fac-
tors. To determine whether Irga6 accumulation at the PVM of
infecting T. gondii also requires other IFNg-inducible factors,
we prepared cloned NIH3T3 ﬁbroblast cell lines (gs3T3)
stably expressing Irga6 under the control of a promoter
inducible by the synthetic steroid, Mifepristone (MIF). On
hormone induction, these cells expressed Irga6 at a level
similar to that in IFNg-induced gs3T3 cells (Supplementary
Figure S3), and the protein accumulated in cytoplasmic
aggregates (Figure 2D) similar to those reported previously
in L929 cells transiently transfected with Irga6. When in-
fected with T. gondii, the accumulation of Irga6 at the PVM
seen in IFNg-treated cells (Martens et al, 2005; Figure 2B and
C) was not detected in MIF-induced cells (Figure 2E and F).
However, when MIF-induced gs3T3-Irga6 cells were simulta-
neously induced with IFNg, normal ER localisation of Irga6
was restored (Figure 2G) and the protein could also accumu-
late normally at the PVM (Figure 2H and I). Thus, cytoplas-
mic aggregation and failure to localise to the PVM are
correlated properties of Irga6 when expressed in the absence
of IFN, and both can be corrected by other IFN-inducible
components.
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pressed Irga6, we generated C-terminally epitope tagged Irga6
constructs (Irga6-ctag1). Irga6-ctag1 transiently transfected
into IFNg-induced mouse embryonic ﬁbroblasts (MEFs)
showed essentially normal resting localisation at the ER and
accumulation at the T. gondii PVM (Figure 2J–L and U),
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Figure 1 Nucleotide binding and hydrolysis by Irga6 and Irga6 mutants. (A–C) Nucleotide-binding afﬁnities of recombinant WT Irga6, -K82A
and -S83N measured by equilibrium titration with mant nucleotides: (A) mGDP, (B) mGTPgS and (C) average dissociation constants (Kd) from
two independent experiments. (D, E) Nucleotide-dependent oligomerisation of WT Irga6 and mutant proteins, measured by (D) conventional
and (E) dynamic light scattering. (F) Kinetics of a
32P-GTP hydrolysis by Irga6 and Irga6 mutants displayed as ratio of the GTP concentration to
the starting concentration against time. (G) Protein concentration dependence of the speciﬁc a
32P-GTP hydrolysis activity of WT Irga6 and
Irga6-K82A measured over 30min.
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normal Irga6 protein function. To test the possibility that
aggregated WT Irga6 in cells not treated with IFNg was
trapped in the GTP-bound state, we examined the properties
of ctag1-tagged Irga6-K82A, in transfected gs3T3 and
MEFs. Irga6-K82A-ctag1 formed cytoplasmic aggregates in
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Figure 2 Subcellular localisation of Irga6 is dependent on IFNg and nucleotide. (A–T) Localisation of Irga6 in uninfected (A, D, G, M, Q) and
T. gondii-infected (B, C, E, F, H, I, J–L, N–P, R–T) ﬁbroblasts. Arrows and arrowheads indicate intracellular T. gondii identiﬁed in phase
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were labelled with DAPI (blue). (A–I) gs3T3-Irga6 cells. (A–C) IFNg-induced cells. (D–F) MIF-induced cells. The second T. gondii visible in (F)
is probably still extracellular. (G–I) IFNg and MIF double-induced cells. Note that not all PVs acquired Irga6 (arrowheads); 70–80% of PVs
acquired Irga6 in IFNg-induced gs3T3 cells (see Figure 4D). (J–L) Infected, IFNg-induced WT MEFs transiently transfected with Irga6-ctag1.
(M–P) Cells transiently transfected with Irga6-K82A-ctag1. (M) Uninduced gs3T3 cells. (N–P) Infected, IFNg-induced WT MEFs. Irga6-K82A-
ctag1 (O) did not transfer to the PVM and inhibited transfer of the endogenous WT Irga6 (N). The non-transfected cell shows a normal PVM
stain with endogenous Irga6 (yellow arrow). (Q–T) Cells transiently transfected with Irga6-S83N-ctag1. (Q) Uninfected gs3T3 cells. (R–T)
Infected, IFNg-induced WT MEFs. (U) Quantiﬁcation of the PVM localisation of Irga6 and its mutants in IFNg-induced, T. gondii-infected gs3T3
cells transiently transfected with WT Irga6-ctag1, -K82A-ctag1 or -S83N-ctag1 (1mg DNA). Transfected proteins were detected by actag1 AS
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Irga6-K82A-ctag1 made similar aggregates in IFNg-induced
cells (Figure 2N). Furthermore, transfected Irga6-K82A-ctag1
almost completely prevented the endogenous IFNg-induced
Irga6 from accumulating at the T. gondii PVM (Figure 2N–P
and U), thus acting functionally as a dominant negative, as
previously reported for T. gondii-infected, IFNg-induced as-
trocytes (Martens et al, 2005). The endogenous Irga6 appar-
ently colocalised in aggregates with the transfected mutant
(Figure 2N and O). These results suggested that cytoplasmic
aggregation and failure to reach the T. gondii PVM are
properties of GTP-bound Irga6, constitutively in the case of
Irga6-K82A and, in the absence of IFNg, also for the WT. The
signiﬁcance of nucleotide binding for the formation of Irga6
aggregates was indicated by the failure of transfected Irga6-
S83N-ctag1 to form aggregates either in IFN-induced or
uninduced cells (Figure 2Q and R). Irga6-S83N protein was
distributed smoothly on cytoplasmic membranes but did not
localise to the T. gondii PVM itself nor did it prevent WT Irga6
from doing so (Figure 2R–U).
These results suggest that WT Irga6 is normally kept in the
cytoplasm in the GDP-bound state in IFNg-induced cells, but
accumulates at the T. gondii PVM in the active GTP-bound
state. In the absence of IFNg, WT Irga6 binds GTP and
activates spontaneously in the cytoplasm to form ‘sterile’
aggregates that cannot localise to the PVM. Irga6-K82A
activates constitutively in the cytoplasm and forms ectopic
GTP-bound aggregates that can also capture WT Irga6, thus
acting as a functional dominant negative. Above all, these
ﬁndings strongly suggest that the nucleotide-binding status of
Irga6 must normally be regulated by other IFNg-inducible
components, and this regulation is essential for the ability of
the protein to localise correctly to PVMs of infecting T. gondii.
The GMS proteins are the IFN-inducible regulators
of Irga6
The non-redundancy documented for several IRG proteins in
resistance to T. gondii suggested that the behaviour of Irga6 in
IFNg-induced cells may be regulated by the presence of other
IRG proteins. We therefore attempted to reconstitute normal
intracellular behaviour of WT Irga6 in the absence of IFNg by
transfecting MIF-induced gs3T3-Irga6 cells with a pool of
expression vectors encoding Irgb6, Irgd, Irgm1, Irgm2 and
Irgm3. Transfected cells identiﬁed by the expression of Irgm2
at the Golgi apparatus (Figure 3B; Martens and Howard,
2006) showed essentially complete restoration of the normal
smooth distribution of Irga6 on the ER, and Irga6 also
accumulated on the T. gondii PVM (Figures 3A–C, 4A and
D). In control cells transfected with EGFPalone, Irga6 showed
the usual cytoplasmic aggregates (Figure 4A). Only the
GMS proteins proved to be necessary for this reconstitution,
but surprisingly all three were required as transfection with
any one or any two of the GMS proteins gave incomplete
phenotypes independent of DNA dose (Figures 3D–I, and 4B
and C and data not shown). Thus, the regulation of Irga6
behaviour in cells is controlled by the three anomalous GMS
GTPases.
It was reported that the mutation S98N in Irgm3, homo-
logous to S83N of Irga6, prevents GTP binding (Taylor et al,
1997). We therefore prepared Irgm3-S98N and the homolo-
gous mutations Irgm1-S90N and Irgm2-S78N to ask whether
the ability of GMS proteins to regulate Irga6 was dependent
on their nucleotide-bound states. The co-transfection of all
three mutant GMS sequences together did not reconstitute
normal Irga6 behaviour in MIF-induced gs3T3-Irga6 cells
(Figures 3J–O, and 4C and D). Thus, regulation of the
nucleotide-bound state of Irga6 by GMS proteins is itself a
nucleotide-dependent process.
Nucleotide-dependent direct interactions between IRGs
in yeast two-hybrid assays
To determine whether nucleotide-dependent interactions be-
tween Irga6 and the GMS proteins involved physical contact,
two yeast two-hybrid (Y2H) systems employing different
DNA-binding (BD) and activation domain (AD) fusion part-
ners for the IRG proteins and different expression properties
were used (see Materials and methods). The IRG proteins
showed multiple interactions in these assay systems and each
family member displayed a distinct pattern of behaviour
(Figure 5A and B). The strong homotypic interaction of
Irga6 observed in the Gal4-based and weak interaction in
the LexAY2H system reproduced the in vitro oligomerisation
of Irga6 in the presence of GTP (Uthaiah et al, 2003),
strengthening the potential in vivo relevance of this interac-
tion. Very strong homotypic interaction was also observed for
Irgb6. As frequently seen in Y2H, the two assay systems
highlighted distinct interactions and some of the interactions
in both systems were unidirectional, probably as a result of
the different structural impacts of the AD and BD on the fused
IRGs (Estojak et al, 1995). Interactions involving Irgm1 were
all weak, though reproducible.
To conﬁrm the speciﬁcity of the interactions seen and to
determine their relevance to the in vivo ﬁndings, the Y2H
assay in the Gal4-based system was repeated with nucleotide-
binding site mutants of the individual proteins. All Y2H
interactions of GMS proteins with other family members
were completely abolished by the GMS to GMN mutants,
Irgm3-S98N, Irgm2-S78N and Irgm1-S90N (Figure 5B).
Likewise, Irga6-S83N was also completely negative for all
interactions displayed by WT Irga6 (Figure 5B). This result is
consistent with the essentially passive behaviour of Irga6-
S83N in ﬁbroblasts (see above). The corresponding mutant of
Irgb6, S70N, similarly failed to show any of the interactions
observed with Irgb6WT. The constitutively active mutant
Irga6-K82A retained many interactions in Y2H (Figure 5B)
including, perhaps surprisingly, the interaction with Irgm3
(see next section) but lost bi-directionality in its interaction
with WT Irga6 and interaction with Irgb6 was completely
abolished. The corresponding mutant of Irgb6, K69A, pre-
served its interactions with WT Irgb6 and Irga6, though the
latter was weakened signiﬁcantly, whereas the interactions
with Irgm2 and Irgm3 were lost (Figure 5B).
Direct interaction between Irga6 and Irgm3
is dependent on GDP
Functionally signiﬁcant nucleotide-dependent interactions
between Irga6 and the GMS proteins occur in IFNg-induced
cells, and the Y2H data suggested that at least some of these
interactions were likely to be direct. The strongest interaction
of Irga6 with a GMS protein in Y2H was with Irgm2
(Figure 5A) and Irgm3 (Figure 5B). Irgm3 localises, like
Irga6, to the ER membrane in IFN-stimulated cells (Taylor
et al, 1997) (Supplementary Figure S4). We accordingly used
puriﬁed recombinant GST-tagged Irga6 bound to glutathione
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transiently transfected with Irgm1, -m2, -m3, -b6 and -d (ﬁve IRGs). (D–I) MIF-induced cells transiently transfected with Irgm1, -m2 and -m3
(three GMS): (D–F) uninfected and (G–I) infected cells. (J–O) MIF-induced cells transiently transfected with Irgm1-S90N, Irgm2-S78N and
Irgm3-S98N (three GMN). (J–L) uninfected and (M–O) infected cells.
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Figure 4 Quantiﬁcation of the effect of GMS proteins on Irga6 localisation. Irga6 localisation in MIF-induced gs3T3-Irga6 cells transiently
transfected with the indicated expression constructs (2mg DNA total; see also Figure 3). (A–C) Effect of other IRG proteins on the resting
localisation of Irga6, recorded as smooth reticular (WT) (white), partly aggregated (grey) and strongly aggregated (black). 150 cells were
counted blind per data point. (A) Cells transfected with Irgm1, -m2, -m3, -b6 and -d (ﬁve IRGs) compared with cells transfected with EGFP. (B)
Cells transfected with single IRG proteins. Each GMS protein alone showed a signiﬁcant beneﬁcial but incomplete effect on Irga6 localisation.
Similar effects were also seen when pairs of GMS proteins were transfected (data not shown). Irgd was inactive. Cells transfected with the Irgb6
showed striking Irgb6 aggregates that largely colocalised with aggregated Irga6 (see also Figure 7A). (C) Cells transfected with a pool of the
three WT GMS proteins were compared with cells transfected with the three inactive GMN mutants. (D) Accumulation of Irga6 at the T. gondii
PV following induction with IFNg, MIF or both, or MIF induction and transfection with Irgm1, -m2, -m3, -b6 and -d, the three GMS proteins or
the three GMN mutants. Data are recorded as the percentage of Irga6-positive PVs per 100 intracellular T. gondii. Around 100 PVs per data point
were counted blind.
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Figure 5 Nucleotide-dependent interactions of IRG proteins in Y2H. Graphic representation of the interaction behaviour of WT and mutant
IRGs observed in Y2H. Interactions were measured by b-galactosidase activity in the LexA system (A) and growth on selective medium in the
Gal4-based system (B). The strengths of the interactions are indicated in shades of grey. ND, not determined.
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treated gs3T3 ﬁbroblasts. In the absence of nucleotide, a very
weak Irgm3 signal was detected. However, Irgm3 was efﬁ-
ciently pulled down upon addition of GDP to the binding
reaction, whereas GTPgS inhibited the interaction completely
(Figure 6A). When the nucleotide-binding deﬁcient mutant
Irga6-S83N was employed in the same assay, no increment in
Irgm3 pull-down above background was seen on addition of
GDP. Thus, Irga6 probably interacts with Irgm3 in the IFNg-
treated cell in the GDP-bound state. That the interaction
between Irga6 and Irgm3 does not depend on other IFNg-
induced intermediaries was shown by a pull down of Irgm3
by Irga6 from MIF-induced gs3T3-Irgm3 cell lysates
(Figure 6B). Again, strong interaction with WT Irga6 required
GDP and was not observed with Irga6-S83N. The identity of
the nucleotide-bound in Irgm3 when interacting with Irga6 is
not clear but may also be GDP in view of the high concentra-
tion (0.5mM) of the nucleotide maintained throughout the
experiment. An interaction between Irga6 and Irgm3 was also
shown by coimmunoprecipitation of Irgm3 with Irga6 from
IFN-induced gs3T3 cells in the presence of exogenous GDP
but not GTPgS (Figure 6C). The interaction was substoichio-
metric and was detected most strongly in the absence of
exogenous nucleotide, presumably reﬂecting complexes
formed in vivo containing trapped endogenous nucleotides
of unknown identity. These experiments conﬁrm the poten-
tial for physical interaction between Irga6 and Irgm3 sug-
gested by the Y2H results. This interaction depends on the
structural integrity of the nucleotide-binding site of Irga6, and
both the pull-down and co-precipitation experiments suggest
that the interaction may be favoured when Irga6 is in the
GDP-bound state. The interaction of Irga6-K82Awith Irgm3 in
Y2H noted above might suggest that GTP binding by Irga6
does not necessarily inhibit the interaction, at least under the
conditions of the Y2H experiments. However, it is unknown
which nucleotide is bound to Irga6-K82A in the interaction
with Irgm3 seen in Y2H. Furthermore, the apparently altered
conformation of Irga6-K82A, which hinders interaction with
WT Irga6 in Y2H (see above), may permit interaction with
Irgm3 even in the presence of GTP.
Regulatory interactions between Irgb6 and the GMS
proteins
Most cell biological properties of Irgb6 resembled those
described for Irga6. Native and C-terminally FLAG-tagged
Irgb6 expressed by transfection in unstimulated cells formed
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Figure 6 Nucleotide-dependent interaction of Irga6 with cellular Irgm3. Pull down of Irgm3 with recombinant GST–WT Irga6 and –Irga6-S83N
protein from IFNg-induced gs3T3 cells (A) and from MIF-induced gs3T3-Irgm3 cells (B) lysed in the presence or absence of guanine
nucleotides. GSTalone served as a negative control. Recombinant protein was visualised by Ponceau S staining of WB membranes (top row).
Irgm3 was detected with aIrgm3 mAb (bottom row). Lys: 4% of lysate input. Dotted lines indicate positions where irrelevant lanes were
removed from the image. (C) Coimmunoprecipitation of Irgm3 with Irga6 from IFNg and non-induced gs3T3 cells in the absence or presence of
exogenous nucleotides. Irga6 was detected on WB membranes with 10D7, Irgm3 with aIGTP mAb. The Irgm3 blot was exposed longer to
visualise the substoichiometric interaction with Irga6 (bottom row 5min, middle and top rows 10s). Lysate: 5% of the input. Arrowhead:
Irgm3; star: heavy chain of the immunoprecipitating AS (165); IP, immunoprecipitated.
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IFNg-induced cells, the aggregates were almost eliminated
(Figure 7B). Irgb6-S70N formed no aggregates (Figure 7C and
D), whereas Irgb6-K69A formed aggregates both in IFNg-
induced and uninduced cells, though some reduction of
aggregates in IFNg-induced cells was observed (Figure 7E
and F). Aggregate formation by transfected Irgb6WT in the
absence of IFNg was eliminated by co-transfection with the
three GMS proteins (Figure 7G and I) but not by co-transfec-
tion of the three GMN mutants (Figure 7H and I). However,
unlike Irga6, WT Irgb6 could accumulate somewhat less
efﬁciently (Figure 7T) on T. gondii PVM in cells not induced
with IFNg, despite the concomitant presence of Irgb6 cyto-
plasmic aggregates (Figure 7J and K). Irgb6-K69A could not
accumulate on the PVM in uninduced cells (Figure7L and M),
but could accumulate in IFNg-induced cells, again in the
presence of cytoplasmic aggregates (Figure 7N and O). Like
Irga6-S83N, Irgb6-S70N was unable to accumulate on the
PVM either in the absence (Figure 7P and Q) or presence
(Figure 7R and S) of IFNg.
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Figure 7 Irgb6 localisation in uninfected and T. gondii-infected ﬁbroblasts. Localisation of transiently transfected (0.5mg per construct), FLAG-
tagged Irgb6 and G1-motif mutants in gs3T3 cells detected with the aFLAG mAb (red in A–H, green in J, L, N, P, R). Irgb6WT in uninduced (A)
or IFNg-induced (B) cells. Irgb6-S70N in uninduced (C) or IFNg-induced (D) cells. Irgb6-K69A in uninduced (E) or IFNg-induced (F) cells.
Irgb6WT plus the three GMS WT (G) or GMN mutant (H) proteins in uninduced cells. Irgm2 (green) was detected with the H53 AS.
(I) Quantiﬁcation of Irgb6 localisation data illustrated in (A, G, H) recorded as smooth reticular WTstaining (white), partly aggregated (grey)
and strongly aggregated (black). A total of 150 cells were counted blind per data point. (J–S) Cells infected with T. gondii. Arrows indicate
intracellular T. gondii identiﬁed in phase contrast. (J, K) Irgb6WT in uninduced cells. Irgb6-K69A in uninduced (L, M) or IFN-induced (N, O)
cells. Irgb6-S70N in uninduced (P, Q) or IFN-induced cells (R, S). (T) The percentage of aFLAG M2 mAb-positive PVs was quantiﬁed in gs3T3
cells transiently transfected with WT Irgb6-FLAG and its mutants in the presence (black bars) and absence (white bars) of IFNg.
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T. gondii PVM in uninduced cells was initially surprising.
However, the results may suggest that in the absence of GMS
proteins, WT Irga6 and Irgb6 establish equilibria between
GTP-bound, aggregated and GDP-bound, free forms, which
are more in favour of GDP in the case of Irgb6 than in the case
of Irga6. In IFNg-induced cells, the biochemically dominant-
positive Irgb6-K69A can perhaps also be partially repaired by
co-expressed GMS proteins, which further push the equili-
brium towards the GDP-bound state and release monomers
that can activate correctly at the PVM, associated with some
reduction of aggregates (Figure 7N).
Localisation of GMS proteins in the absence of IFN
We have shown that GMS proteins are essential regulators of
Irga6 and Irgb6. Unlike the GKS proteins, which have large
cytosolic pools, the GMS proteins are largely or completely
membrane-associated (Martens et al, 2004). Each GMS pro-
tein resides in a distinctive compartment: Irgm1 predomi-
nantly on Golgi (Martens et al, 2004) but also on
endolysosomal membranes (Zhao et al, in preparation),
Irgm2 on Golgi membranes (Martens and Howard, 2006)
and Irgm3 on ER membranes and unidentiﬁed globular
structures (Taylor et al, 1997; Martens et al, 2004) (Figure
8A–C, G–I and M–O; Supplementary Figure S4). These loca-
lisations were faithfully reproduced in uninduced gs3T3 cells
transfected with single expression constructs (data not
shown) and in MIF-induced stable gs3T3 cells (Figure 8D–F,
J–L and P–R). As we show here for Irgm2 and as already
shown for Irgm3 (Taylor et al, 1997) and Irgm1 (Martens
et al, 2004), these localisations were unaffected by the
inactivating GMS to GMN mutations in the G1 motif
(Figure 8S–U).
Both Irgm2 and Irgm3 have been shown to accumulate on
the T. gondii PVM in IFNg-induced, infected cells (Martens
et al, 2005). We found that this accumulation depended on
the presence of other IRG proteins. Thus, it did not occur in
MIF-inducible gs3T3 cell lines expressing only Irgm2 or Irgm3
(data not shown). PVM localisation was also not seen in
unstimulated gs3T3 cells transiently transfected with the
three GMS proteins (Figure 9A–C). However, normal localisa-
tion of Irgm2 and Irgm3 to the T. gondii PVM was restored in
cells transfected with the GKS proteins Irga6, Irgb6 and Irgd
in addition to the three GMS proteins (Figure 9D–I) and when
cells transfected with either Irgm2 or Irgm3 alone were co-
induced with IFNg (data not shown). Under these latter
conditions, the ability of Irgm2 and Irgm3 to accumulate on
the PVM was dependent on the integrity of the G1 motif
(Figure 9J–L and data not shown).
Discussion
We have shown that the cell-autonomous resistance mechan-
ism mediated by the family of IFN-inducible IRG proteins is
underlain by a complex pattern of nucleotide-dependent
interactions between members of the family that determine
both the positioning of the IRG proteins in the cell
before infection and their subsequent ability to target
the PV of the intracellular protozoal pathogen, T. gondii
(see Supplementary Table SI). The three GMS proteins,
Irgm1, Irgm2 and Irgm3, are necessary and sufﬁcient to
determine the normal intracellular localisation, including
accumulation at the T. gondii PVM, of at least two of the
GKS proteins, Irga6 (Figures 3 and 4) and Irgb6 (Figure 7).
The regulatory function of the GMS proteins is dependent on
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Figure 8 Irgm1, Irgm2 and Irgm3 localisation in uninfected ﬁbro-
blasts is independent of IFNg and nucleotide. gs3T3 cells expressing
single GMS proteins were induced with IFNg (A–C, G, H), MIF
(D–F, J–L, P–R) or both (M–O). GMS proteins were colocalised with
markers for deﬁned cellular organelles: (A–F) gs3T3-Irgm3 cells,
(A, D) aIrgm3 mAb; (B, E) aCalnexin AS; (C, F) merge with DAPI.
(G–L) gs3T3-Irgm1 cells, (G, J) aIrgm1 AS; (H, K) aGM130 mAb;
(I, L) merge with DAPI. (M–R) gs3T3-Irgm2 cells; (S–U) gs3T3 cells
transiently transfected with Irgm2-S78N (1mg), (M, P, S) aIrgm2 AS
H53; (N, Q, T) aGiantin mAb; (O, R, U) merge with DAPI.
Endogenous Irgm2 in gs3T3 cells is not detected by H53 AS due
to a polymorphism between C57BL/6 and NIH Swiss mouse strains
(unpublished data).
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and 7), as is the ability of the GKS proteins to relocate to the
PVM (Figures 2 and 7). We also demonstrate direct nucleo-
tide-dependent interactions between GMS and GKS proteins
in Y2H systems (Figure 5). Furthermore, CD-immunoprecipi-
tation and pull-down experiments employing puriﬁed Irga6 to
capture cellular Irgm3, suggest that the nucleotide required
for binding, at least in the case of Irga6, is GDP (Figure 6).
On the basis of these results, we can formulate a tentative
model (Figure 10) of the regulatory regimen that governs
Irga6 (and possibly also Irgb6) in the IFNg-induced cell and
mediates its rapid assembly on the PVM of infecting T. gondii.
In the uninfected cell, we propose that the GMS proteins
interact with GKS proteins in the GDP-bound state and inhibit
uptake of GTP, acting as GDIs (Vetter and Wittinghofer, 2001)
and functionally as attenuators of activation. The GMS
proteins are largely or completely membrane-bound so
these interactions presumably occur at cytoplasmic mem-
branes rather than in the cytosol. Irga6 appears to exist in
equilibrium between cytosol and ER membrane. Cytosolic
Irga6 will be predominantly in the GDP-bound state on the
basis of free cellular nucleotide concentrations (327mM GTP/
91 mM GDP) (Kleineke et al, 1979) and single-site equilibrium
afﬁnity constants of Irga6 for GTP of 15mM and for GDP of
1mM (Uthaiah et al, 2003). GMS proteins should attenuate
GTP uptake by Irga6 primarily at ER membranes because the
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Figure 9 PVM localisation of Irgm2 and Irgm3 is dependent on other IRG proteins and nucleotide. gs3T3 cells infected with T. gondii. Parasites
were detected with aGRA7 mAb (E, green), aT. gondii rabbit (H, red) or goat (C, L, blue) AS, Irga6 with mAb 10E7 (J, green), Irgm2 with H53
AS (B, D, K, red) and Irgm3 with aIrgm3 mAb (A, G, green). Nuclei were stained with DAPI (blue). Arrows indicate intracellular T. gondii.
(A–C) Cells transiently transfected with expression constructs for Irgm1, -m2 and -m3 (666ng each). (D–I) Accumulation of Irgm2 (D–F, red)
and Irgm3 (G–I, green) at the PVM in uninduced cells transiently transfected with six IRGs (Irgm1, -m2, -m3, -a6, -b6 and -d; total 2mg DNA).
(J–L) IFNg-induced cells transiently transfected with Irgm2-S78N (1mg).
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favour local GTP-dependent oligomerisation events at these
endomembranes. The need to inhibit Irga6 (and other GKS
proteins) activation on multiple endogenous membrane sys-
tems may explain why all three GMS proteins are required for
full control of Irga6 and Irgb6 activation. Irgm1 localises to the
Golgi (Martens et al, 2004) and endolysosomal membranes
(Zhao et al, in preparation), Irgm2 to the Golgi (Martens and
Howard, 2006; Figures 3 and 8) and Irgm3 to the ER (Taylor
et al, 1997). We suggest that when GMS proteins are absent,
as in resting cells transfected with Irga6 or when Irga6 is
induced from a synthetic promoter, GTP-dependent oligomer-
isation initiates at cellular membranes and is uncontrolled,
resulting in cytoplasmic aggregates (Figures 2D and 7A) and
deformation of the ER (Supplementary Figure S2). Consistent
with this interpretation is the observation that Irga6-S83N,
which is unable to bind nucleotides (Figure 1), fails to form
aggregates in uninduced cells (Figure 2Q), whereas Irga6-
K82A that binds GTP, but does not measurably hydrolyse it
(Figure 1), develops aggregates even in the IFNg-induced cell
(Figure 2N), either because GMS proteins are unable to
interact normally with the mutant, as indicated by the mod-
iﬁed interactions in Y2H assays (Figure 5B), and/or because
incipient oligomerisation events cannot be terminated by GTP
turnover. Finally, we have shown in a separate study that
Irga6 aggregated in the cytoplasm or accumulated at the
T. gondii PV in IFNg-induced cells expresses an epitope
detected by a monoclonal antibody (mAB), 10D7, that is
dependent on the GTP-bound state of Irga6 (Papic et al,i n
preparation). Similar considerations apply to Irgb6. In support
of the presented model, both Irga6 and Irgb6 form cytoplas-
mic aggregates in IFN-induced bone marrow-derived macro-
phages from Irgm1 and Irgm3 single knockouts as well in
double-deﬁcient mice (Taylor et al, in preparation).
The access of cytosolic, presumably GDP-bound Irga6 or
Irgb6 to the PVM, which is detectable within a few minutes
after infection, may be by simple diffusion, as depolymerisa-
tion of microtubules by nocodazole has no effect on PVM
localisation of Irga6 or Irgb6 (Khaminets et al, in prepara-
tion). We propose that activation of IRG proteins by GTP
binding at the PVM may occur either through a local, perhaps
transient, deﬁciency of GMS proteins at this membrane or
through a speciﬁc, activating interaction with a factor pre-
sumably derived from the T. gondii and expressed on the
cytosolic face of the PVM. Proteins derived from rhoptry
secretions (Dubremetz, 2007) would be strong candidates
for this role in view of their established association with
T. gondii invasion and virulence. As Irga6 forms GTP-dependent
oligomers with accelerated GTPase activity in vitro, the Irga6
observed at the PVM may be in the form of GTP-bound
oligomers, possibly both homo- and hetero-oligomers in
view of the strong nucleotide-dependent interaction in Y2H
between Irga6 and Irgb6 (Figure 5). The membranes of some
PVs also carry Irgm2 and Irgm3, but interestingly only those
that also carry Irga6 and Irgb6 (Khaminets et al, in prepara-
tion). It is possible that these two regulatory GMS proteins
bind secondarily if GDP-bound Irga6 is generated signiﬁ-
cantly at these sites following GTP hydrolysis.
Several non-Ras GTPases have recently been shown to
accelerate GTP hydrolysis by G-domain–G-domain dimerisa-
tion (Sun et al, 2002; Egea et al, 2004; Ghosh et al, 2006;
Scrima and Wittinghofer, 2006), the two G-domains function-
ing effectively as GAP proteins for each other. Such mutually
activating GTPase pairs may be homodimeric (GBP1) or
heterodimeric (SRP, TOC, MnmE). We now know that accel-
erated hydrolysis of GTP in Irga6 oligomers in vitro also
occurs through reciprocal G-domain–G-domain interactions
(Pawlowski et al, in preparation). As noted above, hetero-
oligomeric interactions, as between Irga6 and Irgb6,
may also contribute to events occurring at the PVM in vivo.
By analogy, in the resting state, Irga6 and Irgb6 may be
negatively regulated by heterodimeric G-domain interactions
with GMS members of the IRG family, perhaps by successful
competition with Irga6 and Irgb6 for the G-domain interac-
tion site. The enhancement of Irgm3 pull-down by the addi-
tion of GDP suggests that GDP is an essential cofactor in this
regulation. In the model (Figure 10), we have indicated that
both Irga6 and its GMS attenuator are in the GDP-bound state
but this view, though plausible, needs veriﬁcation by an
in vitro reconstruction of the interaction since Taylor and
colleagues reported some years ago that the guanine nucleo-
tides co-precipitated with Irgm3 from IFNg-induced cells
were 96% GTP to 4% GDP (Taylor et al, 1997).
Unfortunately, nothing is yet known about the hydrolysis,
binding speciﬁcity and afﬁnity of any of the GMS proteins for
nucleotide so it is difﬁcult to put these earlier observations
into context. At present, in the absence of information to the
contrary, the action of the GMS proteins in limiting GDP to
GTP nucleotide exchange, and thus preventing activation of
Irga6 and Irgb6, seems analogous to the action of GDI
proteins in controlling the activation of small GTPases
(Vetter and Wittinghofer, 2001). Interestingly, many GDI
proteins also regulate the shuttling of their target GTPases
between intracellular compartments (DerMardirossian and
Bokoch, 2005), as GMS proteins regulate access of Irga6 to
the T. gondii PVM.
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Figure 10 Model of IRG protein regulation and function in resis-
tance to T. gondii. In the IFN-induced, uninfected cell, GKS IRGs
(red) are held in the inactive, GDP-bound form by transient GDP-
dependent interactions with GMS proteins (green) on endomem-
branes. This membrane-bound form of GKS proteins is in equili-
brium with free monomeric, GDP-bound molecules in the cytosol.
Upon infection with T. gondii, cytosolic GKS molecules reach the
PVM by diffusion. Because of the initial absence of inhibitory GMS
proteins on the PVM, GKS proteins activate by GTP-dependent
homo- and probably also hetero-oligomerisation promoting further
IRG protein accumulation at the PVand ultimately vacuole rupture.
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regulatory interactions with each other may account for some
obscure observations in the IRG ﬁeld. Bernstein-Hanley et al
(2006) observed that overexpression of Irgm3 resulted in
impaired resistance to Chlamydia trachomatis in MEFs, con-
sistent with the here proposed role of Irgm3 as an attenuator
of GKS activation. Second, our data show that GMS proteins
are required for normal regulation of the nucleotide status
and subcellular localisation of Irga6 and Irgb6. Thus, the
susceptibility phenotypes shown by mice with disrupted
Irgm1 or Irgm3 genes may not be due to non-redundant
activity of GMS gene products against the pathogens, but
rather to dysregulation of other IRG proteins. Furthermore,
absence of GMS proteins leads to formation of ectopic
aggregates of the GKS proteins (Figures 2 and 7) that may
have cytopathic consequences. This hints at an explanation
for the lymphomyeloid failure repeatedly observed in Irgm1-
deﬁcient mice infected with strongly immunostimulatory
pathogens such as Mycobacteria (Feng et al, 2004, 2008)
and Trypanosoma (Santiago et al, 2005), if such cytopathic
aggregates form in lymphomyeloid stem cells (Howard,
2007). In this context, Carlow et al (1998) reported problems
recovering transfected clones stably expressing Irgb6 in vitro,
and in those few clones recovered, Irgb6 expression was low
and unstable, again suggesting cytopathic effects of expres-
sing GKS proteins ‘unprotected’ by their GMS regulators.
Finally, regulatory interactions between GMS and GKS
GTPases have been invoked recently, in the absence of a
speciﬁc model, to account for the unexpected phenotype of
mice deﬁcient for both Irgm1 and Irgm3. The severe deﬁ-
ciency in resistance against Salmonella seen in the Irgm1
single-deﬁcient mouse (Henry et al, 2007) was largely re-
versed in the doubly deﬁcient mouse (Taylor et al, in pre-
paration).
Here, we show that IRG proteins function in a system of
nucleotide-dependent interactions that regulate the beha-
viour of these powerful resistance proteins in response to
intracellular infection. Detailed insight into mechanistic as-
pects of these effects will have to await the puriﬁcation of
more IRG family members, in particular of the GMS proteins.
At a functional level, the next challenge is to understand how
the binding and hydrolysis of GTP by IRG proteins localised
to the T. gondii PVM contributes to the destruction of the
vacuole and the subsequent demise of the pathogen.
Materials and methods
Expression constructs
Expression constructs were generated as described in the Supple-
mentary data.
Cell culture
gs3T3 cells (Invitrogen) and C57BL/6 MEFs (Boehm et al, 1998)
were cultured in DMEM, high glucose (Invitrogen), 10% FCS
(Biochrom), 2mM L-glutamine, 1mM sodium pyruvate, 1  MEM
non-essential amino acids, 100U/ml penicillin, 100mg/ml strepto-
mycin (all PAA), transiently transfected using FuGENE6 (Roche)
according to the manufacturer’s instructions, induced with 200U/
ml of mouse IFNg (Cell Concepts) or 10
 9M MIF (Invitrogen)
for 24h.
Generation of inducible cell lines
gs3T3 cells were transfected with linearised pGene-IRG constructs
by calcium phosphate precipitation (Graham and van der Eb, 1973)
and selected for stable integration with 200mg/ml Zeocin (Invivo-
gen). The integrated pSwitch inducer plasmid was maintained with
50mg/ml hygromycin (Invivogen). Clones expressing comparable
protein amounts following MIF and IFNg induction were identiﬁed
by SDS–PAGE and WB (Supplementary Figure S3; see Supplemen-
tary data).
Immunoreagents
Immunoreagents used were aIrga6 165 rabbit antiserum (AS)
(Martens et al, 2004), 10E7 and 10D7 mouse mAbs, aIGTP (Irgm3)
mAb (BD Biosciences), aIrgb6 A20 goat AS and aIrgm1 A19 goat AS
(Santa Cruz Biotechnology), aIrgm2 H53 rabbit AS (Martens et al,
2005), aIrgd 2078 rabbit AS (Martens et al, 2004), aT. gondii rabbit
(BioGenex) and goat AS (Abcam), aGRA7 5-241-178 mouse mAb
(Bonhomme et al, 1998), actag1 2600 rabbit AS (Martens et al,
2005), aGM130 mAb (BD Biosciences), aGiantin mAb (Linstedt and
Hauri, 1993), aCalnexin AS (StressGene), Alexa 350/488/555
labelled donkey amouse, -rabbit and -goat sera (Molecular Probes),
donkey arabbit- (GE Healthcare), donkey agoat- (Santa Cruz
Biotechnology) and goat amouse-HRP (Pierce) AS.
Immunocytochemistry
Immunocytochemistry was performed as described earlier (Martens
et al, 2005), analysed using an Axioplan II ﬂuorescence microscope
and AxioCam MRm camera and images were processed with
Axiovision4 (Zeiss).
Infection of ﬁbroblasts
ME49 strain T. gondii tachyzoites were passaged in vitro and used
for infection of untreated, transiently transfected, IFNg- and/or MIF-
induced ﬁbroblasts at a multiplicity of infection of six for 2h as
described by Martens et al (2005). Intracellular parasites were
identiﬁed by immunostaining for the T. gondii protein GRA7 or in
phase contrast.
Y2H
In the GAL4-based Y2H system, the IRGs were expressed con-
stitutively at low level as N-terminal fusions with the Gal4 BD and
Gal4 AD (James et al, 1996). pGAD- and pGBD-IRG constructs were
lithium acetate transformed (Gietz et al, 1995) into PJ69-4a-a and -a
yeast cells, respectively, followed by selection on synthetic
complete (SC) medium lacking Leu (SC-L) or Trp (SC-T) (James
et al, 1996). Co-expression was achieved by mating on YPD plates
(Sherman, 2002) and selection for diploid cells on SC-L-T. Protein–
protein interaction was determined by growth on SC-L-T also
lacking Ade and His. At least two independent crossings were
performed in each case. The Y2H analysis using the Matchmaker
LexA-system (Clontech) based on inducible expression of the IRGs
as N-terminal fusions with the LexA BD and B42 AD was performed
as described by Kaiser et al (2004) and Kaiser (2005).
Expression and puriﬁcation of recombinant protein
WT Irga6 and mutant proteins were expressed as N-terminal GST
fusions from pGEX-4T-2 constructs in Escherichia coli BL-21 upon
overnight (ON) induction with 0.1mM IPTG at 181C. The cells were
lysed in B1 buffer (PBS/2mM DTT)/Complete Mini Protease
Inhibitor Cocktail, EDTA free (Roche) using a microﬂuidiser
(EmulsiFlex-C5; Avestin). Cleared lysates were puriﬁed on a GSTrap
FF glutathione Sepharose afﬁnity column (GE Healthcare) in B1
buffer. GST was cleaved off by ON incubation of the resin with
thrombin (Serva) at 41C. Free Irga6 was eluted with B1 buffer. Irga6
containing fractions were subjected to size exclusion chromato-
graphy (Superdex 75; GE Healthcare) in B2 buffer (50mM Tris–HCl
pH 7.4, 5mM MgCl2 and 2mM DTT). Pure Irga6 proteins were
concentrated with Vivaspin 20 centrifugal concentrators (Sartorius).
Pull down
IFNg- and MIF-induced gs3T3 cells were lysed for 1h at 41C in lysis
buffer (PBS, 0.1% Thesit (Sigma-Aldrich), 3mM MgCl2, Complete
Mini Protease Inhibitor Cocktail, EDTA free (Roche)) with or
without 0.5mM GDP or GTPgS (Sigma-Aldrich). Postnuclear
supernatants were incubated at 41C ON with glutathione Sephar-
ose-bound (high performance; GE Healthcare) recombinant GST–
Irga6 and –Irga6-S83N that was pre-incubated for 1h with or
without 1mM GDP or GTPgS in PBS, 5mM MgCl2 and 1mM DTT.
Bound cellular proteins were eluted from the washed beads with
elution buffer (30min RT) and subjected to SDS–PAGE and WB.
Input of recombinant Irga6 was monitored by Ponceau S staining.
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IFNg-induced and untreated gs3T3 cells were lysed in lysis buffer in
the absence or presence of 0.5mM GDP and GTPgS (both Sigma-
Aldrich). Irga6-speciﬁc AS 165 was bound to protein A Sepharose
CL-4B (GE Healthcare) and crosslinked using 20mM dimethyl
pimelimidate (Sigma-Aldrich) (Harlow and Lane, 1988). Coupled
beads were incubated with the postnuclear cell lysates for 2h at
41C. Bound proteins were eluted from washed beads with elution
buffer (100mM Tris pH 8.5 and 0.5% SDS) for 30min at room
temperature and subjected to SDS–PAGE and WB. One-quarter of
the eluate was used for detection with aIrga6 mAb 10D7 and three-
quarters for detection with the aIrgm3 mAb.
Guanine nucleotide-binding parameters
The nucleotide-binding afﬁnities of WT Irga6, -K82A and -S83N for
mGDP and mGTPgS (Jena Bioscience) were determined by
equilibrium titration of 0–100mM protein against 0.5mM mant
nucleotides in B2 buffer at 201C. The mant nucleotides were excited
at 355nm, and monitored at 448nm (Aminco-Bowman 2 Lumines-
cence Spectrometer; SLM Instruments). Equilibrium dissociation
constants were obtained as described by Herrmann and Nassar
(1996). The ﬂuorescence emission intensity increases upon binding
of mant nucleotides to GTPases due to exclusion of solvent that
otherwise quenches the ﬂuorophore in solution (Rojas et al, 2003).
Thus, mGTPgS seemed to be more solvent exposed when bound to
Irga6-K82A than to WT Irga6 (Figure 1B).
GTP hydrolysis assay
Here, 80mM WT Irga6 and mutant recombinant proteins were
incubated with 10mM GTP (Sigma-Aldrich) containing traces of
a
32P-labelled GTP (GE Healthcare) at 371C in B2 buffer for up to 3h.
Reactions were separated on PEI Cellulose F TLC plates (Merck) in
1M acetic acid and 0.8M LiCl. Signals were detected with the BAS
1000 phosphoimager analysis system (Fujiﬁlm) and quantiﬁed with
the AIDA Image Analyser v3 software (Raytest). Similar results
were obtained with 1mM GTP and 50mM protein (data not shown).
Oligomerisation assays
Oligomerisation of 80mM Irga6 in the presence of 10mM GDP and
GTP, respectively, in B2 buffer at 371C was determined by
conventional and dynamic light scattering. Conventional light
scattering was performed at 350nm in a DM45 Spectroﬂuorimeter
(Olis) and dynamic light scattering at 650nm with a DynaPro
molecular sizing instrument (Protein Solutions; Wyatt Technolo-
gies). Data were obtained and analysed using the DYNAMICS
software (v.5).
Supplementary data
Supplementary data are available at The EMBO Journal Online
(http://www.embojournal.org).
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